Login Register Cart 0
Generic placeholder image

Current Cardiology Reviews

Editor-in-Chief

ISSN (Print): 1573-403X
ISSN (Online): 1875-6557

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Letter to the Editor

Volatilome: A Novel Tool for Risk Scoring in Ischemic Heart Disease

Author(s): Basheer Abdullah Marzoog*

Volume 20, Issue 6, 2024

Published on: 08 July, 2024

Article ID: e080724231719 Pages: 2

DOI: 10.2174/011573403X304090240705063536

Price: $65

Abstract

Developing a novel risk score for accurate assessment of cardiovascular disease (CVD) morbidity and mortality is an urgent need in terms of early prevention and diagnosis and, thereafter, management, particularly of ischemic heart disease. The currently used scores for the evaluation of cardiovascular disease based on the classical risk factors suffer from severe limitations, including inaccurate predictive values. Therefore, we suggest adding a novel non-classical risk factor, including the level of specific exhaled volatile organic compounds that are associated with ischemic heart disease, to the SCORE2 and SCORE2-OP algorithms. Adding these nonclassical risk factors can be used together with the classical risk factors (gender, smoking, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, diabetes mellitus, arterial hypertension, ethnicity, etc.) to develop a new algorithm and further program to be used widely.

[1]
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics—2023 Update: A report From the American Heart Association. Circulation 2023; 147(8): e93-e621.
[http://dx.doi.org/10.1161/CIR.0000000000001123] [PMID: 36695182]
[2]
Dorresteijn JAN, Visseren FLJ, Wassink AMJ, et al. Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: The SMART risk score. Heart 2013; 99(12): 866-72.
[http://dx.doi.org/10.1136/heartjnl-2013-303640] [PMID: 23574971]
[3]
Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42(34): 3227-337.
[http://dx.doi.org/10.1093/eurheartj/ehab484] [PMID: 34458905]
[4]
de Vries TI, Cooney MT, Selmer RM, et al. SCORE2-OP risk prediction algorithms: Estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J 2021; 42(25): 2455-67.
[http://dx.doi.org/10.1093/eurheartj/ehab312] [PMID: 34120185]
[5]
Hageman S, Pennells L, Ojeda F, et al. SCORE2 risk prediction algorithms: New models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J 2021; 42(25): 2439-54.
[http://dx.doi.org/10.1093/eurheartj/ehab309] [PMID: 34120177]
[6]
Nurmohamed NS, Kraaijenhof JM, Mayr M, et al. Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction. Eur Heart J 2023; 44(18): 1594-607.
[http://dx.doi.org/10.1093/eurheartj/ehad161] [PMID: 36988179]
[7]
Močnik M, Marčun Varda N. Lipid biomarkers and atherosclerosis—old and new in cardiovascular risk in childhood. Int J Mol Sci 2023; 24(3): 2237.
[http://dx.doi.org/10.3390/ijms24032237] [PMID: 36768558]
[8]
Marzoog BA. Endothelial dysfunction under the scope of arterial hypertension, coronary heart disease, and diabetes mellitus using the angioscan. Cardiovasc Hematol Agents Med Chem 2024; 22(2): 181-6.
[http://dx.doi.org/10.2174/0118715257246589231018053646] [PMID: 37921186]
[9]
Marzoog BA, Vlasova TI. Membrane lipids under norm and pathology. European J Clin Exp Med 2021; 19(1): 59-75.
[http://dx.doi.org/10.15584/ejcem.2021.1.9]
[10]
Marzoog BA. Tree of life: Endothelial cell in norm and disease, the good guy is a partner in crime! Anat Cell Biol 2023; 56(2): 166-78.
[http://dx.doi.org/10.5115/acb.22.190] [PMID: 36879408]
[11]
Zhu D, Vernon ST, D’Agostino Z, et al. Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort. Biomolecules 2023; 13(6): 917.
[http://dx.doi.org/10.3390/biom13060917] [PMID: 37371497]
[12]
Dugani SB, Moorthy MV, Li C, et al. Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women. JAMA Cardiol 2021; 6(4): 437-47.
[http://dx.doi.org/10.1001/jamacardio.2020.7073] [PMID: 33471027]
[13]
Marzoog BA. Recent advances in molecular biology of metabolic syndrome pathophysiology: Endothelial dysfunction as a potential therapeutic target. J Diabetes Metab Disord 2022; 21(2): 1903-11.
[http://dx.doi.org/10.1007/s40200-022-01088-y] [PMID: 36065330]
[14]
Marzoog BA. Endothelial cell autophagy in the context of disease development. Anat Cell Biol 2023; 56(1): 16-24.
[http://dx.doi.org/10.5115/acb.22.098] [PMID: 36267005]
[15]
Marzoog B. Breathomics detect the cardiovascular disease: Delusion or dilution of the metabolomic signature. Curr Cardiol Rev 2024; 20(4): e020224226647.
[http://dx.doi.org/10.2174/011573403X283768240124065853] [PMID: 38318837]
[16]
Abdullah Marzoog B. Caveolae’s behavior in norm and pathology. Emir Med J 2023; 4(2): e080523216639.
[http://dx.doi.org/10.2174/0250688204666230508112229]
[17]
Marzoog BA. The metabolic syndrome puzzles; possible pathogenesis and management. Curr Diabetes Rev 2023; 19(4): e290422204258.
[http://dx.doi.org/10.2174/1573399818666220429100411] [PMID: 35507784]
[18]
Kist JM, Vos RC, Mairuhu ATA, et al. SCORE2 cardiovascular risk prediction models in an ethnic and socioeconomic diverse population in the Netherlands: An external validation study. EClinMed 2023; 57: 101862.
[http://dx.doi.org/10.1016/j.eclinm.2023.101862] [PMID: 36864978]
[19]
Brunström M, Andersson J, Eliasson M, Fu M, Hansson P-O, Söderberg S. SCORE2 - an updated model for cardiovascular risk prediction Lakartidningen 2021; 2021: 118.
[20]
Yari A, Ueda P, Hagstrom E, et al. Distribution of cardiovascular disease risk according to SCORE2 and potential need for cholesterol and blood pressure lowering therapy in apparently healthy middle-aged individuals Eur Heart J 2022; 43(Suppl. 2): ehac544.2279.
[http://dx.doi.org/10.1093/eurheartj/ehac544.2279]
[21]
Marzoog BA, Abdullaev M, Suvorov A, et al. Single channel electrocardiography optimizes the diagnostic accuracy of bicycle ergometry! medRxiv 2024.
[http://dx.doi.org/10.1101/2024.04.20.24306122]
[22]
Kasim SS, Ibrahim N, Malek S, et al. Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population. Lancet Reg Health - Western Pac 2023; 35: 100742.
[http://dx.doi.org/10.1016/j.lanwpc.2023.100742] [PMID: 37424687]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy